Diabetes raises odds of invasive erectile dysfunction treatment

Men with diabetes were 50% more likely to undergo second-stage invasive treatment for erectile dysfunction and more than twice as likely to have third-stage therapy for ED than those without diabetes, a study found. The findings presented at the annual meeting of American Urological Association suggest that erectile dysfunction in men with diabetes is less likely to respond to oral drugs, progresses faster or both, a researcher said.

Share

This news summary appeared in ANA SmartBrief on 05/27/2011
Click here to view the full issue.


View the original article:
Medscape (free registration)

Want to see more news summaries?
Sign up for ANA SmartBrief

ANA SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news summaries like the one to the left
Sign up:
About SmartBrief
SmartBrief is the leading online publisher of targeted business news and information by industry. By combining technology and editorial expertise, SmartBrief filters thousands of sources daily to deliver the most relevant industry news in partnership with more than 180 trade associations, professional societies nonprofits and corporate entities